r/valueinvesting will somehow spin this as a positive
TehWildMan_ on
Ouch. RIP me
atape_1 on
Patients taking a 2.4 mg dose of CagriSema achieved a weight loss of 23% after 84 weeks compared to 25.5% with a 15 mg dose of tirzepatide, Novo said.
That is such a small difference. I wonder what the side effect profile was and the muscle mass loss. If the Novo Nordisk has fewer side effects and more muscle mass retention, than honestly it is a win.
Also if Novo Nordisk can match the performance with higher dosage, than it’s really a non issue. Might be a good time for a long term hold buy.
EDIT: They have not published a paper yet on the trial, just the short communication, when the paper comes out, pay close attention to the side effects and muscle loss, if that is favorable, the market will follow, because that is the main problem of this class of drugs, and pretty much anyone would sacrifice a bit of efficacy for muscle mass retention.
Remarkable-Fox-1429 on
Karma
pain474 on
Doesn’t make any significant difference for the fatties irl, I will buy when it hits 35$.
abradolphlincler420 on
R/value investing in a shambles
curiousguy1993 on
Bullish news for HiMS I guess 😅
Flexlex724 on
Way over sold…..3% difference don’t mean much for regular people. Price point is what matters now
i_made_a_mitsake on
its joever
arctics_seagull on
No slim latinas
manu144x on
Upon investors hearing this, Tesla stock went up another 5%
kwijibokwijibo on
Oooof, right in my calls
future2300 on
Was about to buy calls last week, seems like I’m buying the dip now…
Kickboy21 on
Theres someone out there who is thinking about how much of a discount this is and become a future NVO bagholder
15 Comments
r/valueinvesting will somehow spin this as a positive
Ouch. RIP me
Patients taking a 2.4 mg dose of CagriSema achieved a weight loss of 23% after 84 weeks compared to 25.5% with a 15 mg dose of tirzepatide, Novo said.
That is such a small difference. I wonder what the side effect profile was and the muscle mass loss. If the Novo Nordisk has fewer side effects and more muscle mass retention, than honestly it is a win.
Also if Novo Nordisk can match the performance with higher dosage, than it’s really a non issue. Might be a good time for a long term hold buy.
EDIT: They have not published a paper yet on the trial, just the short communication, when the paper comes out, pay close attention to the side effects and muscle loss, if that is favorable, the market will follow, because that is the main problem of this class of drugs, and pretty much anyone would sacrifice a bit of efficacy for muscle mass retention.
Karma
Doesn’t make any significant difference for the fatties irl, I will buy when it hits 35$.
R/value investing in a shambles
Bullish news for HiMS I guess 😅
Way over sold…..3% difference don’t mean much for regular people. Price point is what matters now
its joever
No slim latinas
Upon investors hearing this, Tesla stock went up another 5%
Oooof, right in my calls
Was about to buy calls last week, seems like I’m buying the dip now…
Theres someone out there who is thinking about how much of a discount this is and become a future NVO bagholder
https://preview.redd.it/fh4rqtumg8lg1.jpeg?width=1079&format=pjpg&auto=webp&s=e58ab868e6803f32b22707b7915399c60dd9a402